Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06008210
Other study ID # 14118622
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2023
Est. completion date May 31, 2025

Study information

Verified date May 2024
Source Food and Health Bureau, Hong Kong
Contact Helen Chan, Ph.D.
Phone 39438099
Email helencyl@cuhk.edu.hk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to support EOL decision-making in patients with advanced COPD and their family members. A parallel two-arm single-blinded randomised controlled trial will be conducted to evaluate the effects of a specific decision support intervention. A total of 226 patients with advanced COPD and their designated family members will be recruited from hospital wards and outpatient clinics.


Description:

Chronic Obstructive Pulmonary Disease (COPD) is a progressive life-limiting condition. However, patients with advanced COPD and their family members generally are unprepared for end-of-life (EOL) situations. The Ottawa Decision Support Framework model is adopted to address the patients' decisional needs for the difficult decisions in EOL care. The participants will be randomly allocated to either the intervention group to receive the decision support intervention or the control group to receive general health coaching. Outcomes will be measured at baseline and 1- and 6-month post-allocation. Subsequently, a descriptive qualitative study will be conducted with a subsample of 30 dyads to explore how the intervention influenced the study outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 226
Est. completion date May 31, 2025
Est. primary completion date May 31, 2025
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria of patients: - are aged 50 years or over - have been diagnosed with COPD - are cognitively sound (scored > 5 on the validated Abbreviated Mental Test (Hong Kong version) [AMT-HK]) - meet at least two of the six specific clinical indicators related to advanced COPD in the Gold Standards Framework (GSF) Proactive Identification Guidance, 6th Edition - can nominate a family member who would take part in their healthcare decision- making. Inclusion Criteria of patients' family members: - are aged 18 years or over, - can communicate in Cantonese, - have at least one personal contact per week with the patient in the past 6 months and - are willing to join the study. Family members will be excluded if they score < 6 on the AMT-HK or are expecting to leave Hong Kong within the next 6 months. Exclusion Criteria: - non-communicable due to a severe hearing impairment, dysphasia or a language barrier; - are receiving palliative care services or - have already completed ACP or an advance directive.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Decision Support Intervention
The participants will receive two 60-minute consultation sessions delivered by a trained nurse in four weeks at home. Participant's family members will be encouraged to attend the sessions. In the first session, the nurse will explore the participant's understanding of the current health condition, introduce the concept of advance care planning and discuss their decisional needs for end-of-life care decision-making. In the second session, the nurse will ask the participants to complete a value clarification exercise individually.
Health Coaching
The participants will receive two 60-minute health coaching sessions delivered by a trained nurse in four weeks at home. This intervention will focus on lifestyle modification and self-care management unrelated to the tested intervention content or outcomes.

Locations

Country Name City State
China Prince of Wales Hospital Hong Kong
China Tai Po Hospital Hong Kong

Sponsors (2)

Lead Sponsor Collaborator
Food and Health Bureau, Hong Kong Hospital Authority, Hong Kong

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Decisional conflict at T0 Decisional conflict regarding EOL care measured using The SURE test. It includes four items to be rated on a dichotomous format, with 0 (no) or 1 (yes). The total score ranged from 0 to 4, with a higher score means less decisional conflict. Baseline
Primary Decisional conflict at T1 Decisional conflict regarding EOL care measured using The SURE test. It includes four items to be rated on a dichotomous format, with 0 (no) or 1 (yes). The total score ranged from 0 to 4, with a higher score means less decisional conflict. 1-month post allocation
Primary Decisional conflict at T2 Decisional conflict regarding EOL care measured using The SURE test. It includes four items to be rated on a dichotomous format, with 0 (no) or 1 (yes). The total score ranged from 0 to 4, with a higher score means less decisional conflict. 6-month post allocation
Secondary Self-efficacy for ACP at T0 Self-efficacy for ACP measured using the 3-item Self-efficacy subscale of the ACP Engagement Survey. Participants will rate their level of self-efficacy regarding three ACP actions - namely, appointing a surrogate and discussing EOL care with a surrogate and with medical doctors - using a five-point Likert scale. A higher score indicates a higher level of self-efficacy. Baseline
Secondary Self-efficacy for ACP at T1 Self-efficacy for ACP measured using the 3-item Self-efficacy subscale of the ACP Engagement Survey. Participants will rate their level of self-efficacy regarding three ACP actions - namely, appointing a surrogate and discussing EOL care with a surrogate and with medical doctors - using a five-point Likert scale. A higher score indicates a higher level of self-efficacy. 1-month post allocation
Secondary Self-efficacy for ACP at T2 Self-efficacy for ACP measured using the 3-item Self-efficacy subscale of the ACP Engagement Survey. Participants will rate their level of self-efficacy regarding three ACP actions - namely, appointing a surrogate and discussing EOL care with a surrogate and with medical doctors - using a five-point Likert scale. A higher score indicates a higher level of self-efficacy. 6-month post allocation
Secondary Readiness for ACP at T0 Readiness for completing the aforementioned three ACP actions based on the ACP Engagement Survey. Participants will rate their readiness using a five-point scale, from 1 (never thought about it) to 5 (completed already). The total score ranged from 4 to 20. A higher score indicates a higher level of readiness. Baseline
Secondary Readiness for ACP at T1 Readiness for completing the aforementioned three ACP actions based on the ACP Engagement Survey. Participants will rate their readiness using a five-point scale, from 1 (never thought about it) to 5 (completed already). The total score ranged from 4 to 20. A higher score indicates a higher level of readiness. 1-month post allocation
Secondary Readiness for ACP at T2 Readiness for completing the aforementioned three ACP actions based on the ACP Engagement Survey. Participants will rate their readiness using a five-point scale, from 1 (never thought about it) to 5 (completed already). The total score ranged from 4 to 20. A higher score indicates a higher level of readiness. 6-month post allocation
Secondary Family members' engagement in ACP at T0 Family members' engagement in ACP will be measured by using the 17-item ACP Engagement Survey for Surrogate Decision Makers. Participants will rate their level of engagement using a five-point scale, from 1 (least) to 5 (highest). The total score ranged from 17 to 85. A higher score indicates a higher level of engagement. Baseline
Secondary Family members' engagement in ACP at T1 Family members' engagement in ACP will be measured by using the 17-item ACP Engagement Survey for Surrogate Decision Makers. Participants will rate their level of engagement using a five-point scale, from 1 (least) to 5 (highest). The total score ranged from 17 to 85. A higher score indicates a higher level of engagement. 1-month post allocation
Secondary Family members' engagement in ACP at T2 Family members' engagement in ACP will be measured by using the 17-item ACP Engagement Survey for Surrogate Decision Makers. Participants will rate their level of engagement using a five-point scale, from 1 (least) to 5 (highest). The total score ranged from 17 to 85. A higher score indicates a higher level of engagement. 6-month post allocation
Secondary End-of-life care preferences at T1 End-of-life care preferences will be determined using the adapted Life-Support Preferences Questionnaire. Participants will be asked to indicate whether they would accept cardiopulmonary resuscitation, mechanical ventilator and tube feeding if they become seriously ill and mentally incapacitated. There are three options: yes, no and uncertain. In addition, they will be asked to indicate their preferred goal of end-of-life care. The available options are maintain life at all costs, maintain comfort and uncertain. There is no scoring for the responses. 1-month post allocation
Secondary End-of-life care preferences at T2 End-of-life care preferences will be determined using the adapted Life-Support Preferences Questionnaire. Participants will be asked to indicate whether they would accept cardiopulmonary resuscitation, mechanical ventilator and tube feeding if they become seriously ill and mentally incapacitated. There are three options: yes, no and uncertain. In addition, they will be asked to indicate their preferred goal of end-of-life care. The available options are maintain life at all costs, maintain comfort and uncertain. There is no scoring for the responses. 6-month post allocation
Secondary Advance directives at T2 Participants will be asked if they have completed advance directives in the past six months. 6-month post allocation
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03923660 - Ventilatory Adaptation to Concentric Versus Eccentric Exercise in Patients With Severe COPD N/A
Recruiting NCT05029349 - Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease) N/A
Not yet recruiting NCT05539547 - Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD Early Phase 1
Recruiting NCT04018729 - Cell Therapy Associated With Endobronchial Valve Phase 2/Phase 3
Suspended NCT04848012 - Efficacy of an Advanced Auto-titrating NIV in COPD N/A
Recruiting NCT06198309 - Risk Prediction Model for Exacerbating Phenotype in Patients With Chronic Obstructive Pulmonary Disease
Recruiting NCT03398772 - Effects of a Comprehensive Health Coaching Program in Advanced Chronic Obstructive Pulmonary Disease. N/A
Recruiting NCT06247397 - Effect of HIgh-flow Therapy in Long-term Oxygen Therapy N/A
Completed NCT05259280 - Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD N/A
Not yet recruiting NCT06212765 - Oral Citrulline Supplementation in COPD Patients With Malnutrition Phase 3
Completed NCT02962999 - Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation Phase 4
Not yet recruiting NCT06229509 - Study of the Cytokine Response During Exercise Dyspnea in Patients With Chronic Obstructive Pulmonary Disease (COPD). Effect of Body Composition N/A
Completed NCT05431218 - Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD Phase 4
Recruiting NCT04069312 - Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) Phase 4
Recruiting NCT05575336 - Assessment of the Effectiveness, Socio-economic Impact and Implementation of a Digital Solution for Severe Patients N/A
Completed NCT02998515 - Effects of Different Oxygen Devices in Hypoxemic COPD Patients N/A
Completed NCT04533516 - Additional Manual Therapy Over Inspiratory Muscle Training in COPD N/A
Recruiting NCT06072690 - Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease